Cargando…
Slower Fibrosis Progression Among Liver Transplant Recipients With Sustained Virological Response After Hepatitis C Treatment
BACKGROUND: The natural course of hepatic fibrosis in HCV allograft recipients with sustained virological response (SVR) after anti-HCV therapy remains debatable. The aim of this study was to examine the progression of fibrosis in a cohort of patients who achieved SVR compared with those without tre...
Autores principales: | Habib, Shahid, Meister, Edward, Habib, Sana, Murakami, Traci, Walker, Courtney, Rana, Abbas, Shaikh, Obaid S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elmer Press
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5051041/ https://www.ncbi.nlm.nih.gov/pubmed/27785303 http://dx.doi.org/10.14740/gr686w |
Ejemplares similares
-
Hepatitis C in Liver Allograft Recipients: Utility of One-Year Post-Transplantation Biopsy as an Indicator of Antiviral Therapy
por: Habib, Shahid, et al.
Publicado: (2015) -
Differential Simultaneous Liver and Kidney Transplant Benefit Based on Severity of Liver Damage at the Time of Transplantation
por: Habib, Shahid, et al.
Publicado: (2017) -
Efficacy of Low Dose Chemoprophylaxis for Coccidioidomycosis Infection in Liver Transplant Recipients
por: Habib, Shahid, et al.
Publicado: (2019) -
The “slower” the better
por: Pala, L., et al.
Publicado: (2014) -
2732. Peri-Operative Antibiotic Management for Lung Transplant Recipients with Cystic Fibrosis
por: Gordon, Melissa, et al.
Publicado: (2023)